Apatinib has been evaluated across numerous clinical trials spanning Early Phase 1 through Phase 3. Sponsored by academic institutions such as Sun Yat-sen University and Fudan University, alongside pharmaceutical companies including Jiangsu Hengrui Medicine and Elevar Therapeutics, this research focuses primarily on solid tumors, including hepatocellular carcinoma, biliary tract cancer, relapsed ovarian cancer, advanced gastric cancer, and triple-negative breast cancer. These global trials encompass a range of recruitment statuses, from actively recruiting and completed to suspended or unknown.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT07371910 | ACTIVE_NOT_RECRUITING | Metastatic Breast Cancer; HRD-Positive/HER2-Negative Advanced Breast Cancer |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2024-06-12 | PHASE3 |
| NCT06255392 | RECRUITING | Fludzoparib" and Anti-angiogenic; HRD-positive/HER2-negative Advanced Breast Cancer |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2024-06-12 | PHASE3 |
| NCT02493582 | ACTIVE_NOT_RECRUITING | Adenocarcinoma of Lung |
The First People's Hospital of Changzhou |
2015-07 | PHASE2 |
| NCT02485015 | ACTIVE_NOT_RECRUITING | Stomach Neoplasms |
The First People's Hospital of Changzhou |
2015-06 | PHASE2 |
| NCT07587034 | NOT_YET_RECRUITING | Liver Cancer |
Shanghai Zhongshan Hospital |
2026-06 | PHASE1; PHASE2 |
| NCT07267806 | RECRUITING | Hepato Cellular Carcinoma (HCC); Chemotherapy Effect |
Linhui Peng |
2025-10-31 | PHASE3 |
| NCT06881017 | NOT_YET_RECRUITING | Gastric Cancer; HER2 + Gastric Cancer; CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction; PD-L1 Positive |
China Medical University, China |
2025-05-01 | PHASE2 |
| NCT06771154 | NOT_YET_RECRUITING | Recurrent/Metastatic Endometrial Cancer |
Peking Union Medical College Hospital |
2025-04-01 | PHASE2 |
| NCT06181032 | RECRUITING | Biliary Tract Malignancies |
First Affiliated Hospital of Fujian Medical University |
2023-12-23 | PHASE1 |
| NCT07802184 | NOT_YET_RECRUITING | Locally Advanced Pancreatic Cancer; Metastatic Pancreatic Cancer |
West China Hospital |
2026-09-10 | PHASE1; PHASE2 |
| NCT06889688 | RECRUITING | Breast Cancer Stage IV; Triple -Negative Breast Cancer |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2025-02-21 | PHASE3 |
| NCT07589244 | RECRUITING | HCC |
Guangzhou Virotech Pharmaceutical Co., Ltd. |
2026-05-13 | PHASE2; PHASE3 |
| NCT07790419 | NOT_YET_RECRUITING | Liver Cancer |
Zhai Wenlong |
2026-08-30 | PHASE4 |
| NCT07610629 | NOT_YET_RECRUITING | Gastric Adenocarcinoma |
Henan Cancer Hospital |
2026-05-05 | PHASE2 |
| NCT07569679 | RECRUITING | Biliary Tract Cancer |
Air Force Military Medical University, China |
2025-12-10 | PHASE2 |
| NCT07357532 | NOT_YET_RECRUITING | Small Cell Lung Carcinoma |
Peking University Cancer Hospital & Institute |
2026-01-31 | PHASE2 |
| NCT04803539 | RECRUITING | Breast Cancer |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2021-04-01 | PHASE2; PHASE3 |
| NCT06773156 | ENROLLING_BY_INVITATION | Limited-stage Small Cell Lung Cancer (LS-SCLC) |
Second Affiliated Hospital of Nanchang University |
2024-11-01 | PHASE2 |
| NCT06172205 | RECRUITING | BCLC Stage C Hepatocellular Carcinoma; Chemotherapy Effect |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2023-07-01 | PHASE3 |
| NCT06666166 | NOT_YET_RECRUITING | Advanced Gastric Carcinoma; Advanced Gastroesophageal Junction Adenocarcinoma; Advanced Colorectal Cancer |
Yunpeng Liu |
2024-12 | PHASE2 |
| NCT07749859 | NOT_YET_RECRUITING | Advanced Unresectable Hepatocellular Carcinoma |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
2026-08 | PHASE2 |
| NCT07464756 | RECRUITING | Gastric Adenocarcinoma |
The First Affiliated Hospital with Nanjing Medical University |
2026-04-03 | PHASE2 |
| NCT06339619 | RECRUITING | Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2024-03-11 | PHASE2 |
| NCT07353684 | RECRUITING | Adebrelimab; Adenocarcinoma of GE Junction; Adenocarcinoma of Stomach |
Beijing Friendship Hospital |
2025-05-11 | PHASE2 |
| NCT07324473 | NOT_YET_RECRUITING | Hepatocellular Carcinomas; Resistance to Immunotherapy; Immunomodulation; Drug Repurposing |
First Affiliated Hospital of Chongqing Medical University |
2026-01-01 | PHASE2 |
| NCT07653451 | NOT_YET_RECRUITING | Esophageal Squamous Cell Carcinoma |
Peking University Cancer Hospital & Institute |
2026-07-01 | PHASE2; PHASE3 |
| NCT06925243 | RECRUITING | Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ]); Neoadjuvant Therapy; Adjuvant Chemotherapy; pCR Rate; MPR; ORR,OS,PFS |
Zuoyi Jiao |
2025-04-15 | PHASE3 |
| NCT07236528 | NOT_YET_RECRUITING | Mucosal Melanoma |
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School |
2025-11-30 | PHASE2 |
| NCT07154082 | RECRUITING | Hepatocellular Carcinoma (HCC) |
Wei Zhang |
2025-12-30 | PHASE2 |
| NCT05582499 | RECRUITING | Breast Neoplasm; Breast Cancer; Breast Tumors; Triple-Negative Breast Cancer (TNBC); HER2-positive Breast Cancer; HER2-negative Breast Cancer; Hormone Receptor Positive Tumor; Hormone Receptor Negative Tumor; Early-stage Breast Cancer; Locally Advanced Breast Cancer |
Fudan University |
2022-11-01 | PHASE2 |
| NCT07371871 | NOT_YET_RECRUITING | Advanced Gastric Cancer |
Anhui Provincial Cancer Hospital |
2026-01-08 | |
| NCT07314372 | NOT_YET_RECRUITING | Unresectable Hepatocellular Carcinoma (HCC); Hepatocellular Carcinoma (HCC); Liver Cancer Adult |
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School |
2026-02-01 | PHASE2 |
| NCT07334483 | RECRUITING | HCC |
GrandPharma (China) Co., Ltd. |
2025-08-22 | PHASE2 |
| NCT07773363 | NOT_YET_RECRUITING | Pancreatic Cancer |
Tang-Du Hospital |
2026-08-30 | PHASE2 |
| NCT06614621 | NOT_YET_RECRUITING | Extensive-Stage Small Cell Lung Cancer |
Fujian Cancer Hospital |
2025-02-01 | PHASE2 |
| NCT06749691 | RECRUITING | Small Cell Lung Cancer Extensive Stage |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2024-12-28 | PHASE2 |
| NCT05192798 | RECRUITING | Triple-negative Breast Cancer |
The First Affiliated Hospital of Bengbu Medical University |
2022-01-14 | PHASE2 |
| NCT03020979 | RECRUITING | Malignant Ascites; Apatinib |
The First Affiliated Hospital of Bengbu Medical University |
2017-01 | PHASE2 |
| NCT07289997 | RECRUITING | AFP Gastric or Gastroesophageal Junction Adenocarcinoma; PD-1/CTLA-4; AFPGC; Immunotherapy |
Hebei Medical University Fourth Hospital |
2025-09-28 | PHASE2 |
| NCT07314203 | NOT_YET_RECRUITING | Gastric Cancer; Surgery |
Fujian Medical University |
2026-12-25 | PHASE3 |
| NCT07105748 | RECRUITING | Mixed Hepatocellular-cholangiocarcinoma |
Fudan University |
2025-08-15 | PHASE2 |
| NCT06786312 | NOT_YET_RECRUITING | Small Cell Lung Cancer Extensive Stage |
Fujian Cancer Hospital |
2025-01-25 | PHASE2 |
| NCT07294664 | RECRUITING | Advanced Gastric Cancer; SHR1701 |
The First Affiliated Hospital of Zhengzhou University |
2025-06-15 | PHASE2 |
| NCT07682272 | NOT_YET_RECRUITING | Resectable Hepatocellular Carcinoma With Intermediate or High Recurrence Risk |
Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
2026-07 | PHASE2 |
| NCT07135544 | RECRUITING | Biliary Tract Cancer; Biliary Tract Cancer (CCA) |
Yongjun Chen |
2025-08-14 | PHASE2 |
| NCT07033819 | RECRUITING | Ovarian Cancer |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
2025-06-25 | PHASE2 |
| NCT06925516 | RECRUITING | Intrahepatic Cholangiocarcinoma (Icc) |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2025-04-25 | PHASE2 |
| NCT07192848 | NOT_YET_RECRUITING | Hepatocellular Carcinoma Non-resectable |
Song Peng |
2025-09 | PHASE2 |
| NCT06385873 | NOT_YET_RECRUITING | Gastric Cancer/Gastroesophageal Junction Adenocarcinoma |
The First Affiliated Hospital with Nanjing Medical University |
2024-05-01 | PHASE2 |
| NCT06973330 | NOT_YET_RECRUITING | AFP Gastric or Gastroesophageal Junction Adenocarcinoma |
Anhui Provincial Cancer Hospital |
2025-07 | PHASE2 |
| NCT06537505 | NOT_YET_RECRUITING | Solid Tumor |
Beidahuang Industry Group General Hospital |
2024-08-05 | PHASE2 |
| NCT07618546 | NOT_YET_RECRUITING | HCC - Hepatocellular Carcinoma |
Henan Cancer Hospital |
2026-05-25 | |
| NCT06280508 | RECRUITING | Resectable Intrahepatic Cholangiocarcinoma With High Risk of Recurrence |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2024-03-01 | PHASE2 |
| NCT06360042 | RECRUITING | Unresectable Hepatocellular Carcinoma |
Peking University Cancer Hospital & Institute |
2024-01-01 | PHASE2 |
| NCT06893887 | RECRUITING | Hepatocellular Carcinoma(HCC) |
Nanjing Tianyinshan Hospital |
2025-05-22 | |
| NCT07479732 | RECRUITING | Osteosarcoma; Osteosarcoma Metastatic |
Peking University People's Hospital |
2026-03-05 | PHASE1; PHASE2 |
| NCT06296563 | RECRUITING | Intrahepatic Cholangiocarcinoma |
Lei ZHAO |
2024-03-01 | PHASE2 |
| NCT06447623 | RECRUITING | Advanced Breast Cancer; HR+/HER2- Breast Cancer |
Fudan University |
2024-02-01 | PHASE3 |
| NCT06745193 | NOT_YET_RECRUITING | Advanced Esophageal Carcinoma |
Peking University |
2025-02-01 | PHASE2 |
| NCT07031154 | NOT_YET_RECRUITING | Non-Small Cell Lung Cancer; Adebrelimab; Apatinib |
The First Affiliated Hospital of Xiamen University |
2025-06-30 | PHASE2 |
| NCT06759090 | NOT_YET_RECRUITING | Metastatic Pancreatic Carcinoma |
Zhejiang University |
2025-01-15 | PHASE2 |
| NCT06831175 | RECRUITING | Adrenal Cortical Carcinoma; Adrenal Cortical Cancer; Adrenal Cancer |
West China Hospital |
2025-03-15 | PHASE2 |
| NCT06099821 | RECRUITING | Digestive System Cancers |
Peking University Cancer Hospital & Institute |
2023-10-25 | PHASE2 |
| NCT05139095 | RECRUITING | Gestational Trophoblastic Neoplasia |
Peking Union Medical College Hospital |
2022-01-27 | PHASE2 |
| NCT06749730 | RECRUITING | Unresectable Biliary Tract Carcinoma |
Henan Cancer Hospital |
2024-04-01 | PHASE2 |
| NCT06538935 | NOT_YET_RECRUITING | Hepatocellular Carcinoma; SBRT; Immune Checkpoint Blockade; Tyrosine Kinase Inhibitor |
Fujian Cancer Hospital |
2025-01 | PHASE2 |
| NCT06576973 | RECRUITING | Esophageal Squamous Cell Carcinoma; Neoadjuvant Treatment |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2024-08-08 | PHASE2 |
| NCT07770113 | RECRUITING | GC/GEJC |
The First Affiliated Hospital of Zhengzhou University |
2025-06-30 | PHASE2 |
| NCT06351020 | ACTIVE_NOT_RECRUITING | Locally Advanced or Metastatic GC and GCJ Adenocarcinoma |
LaNova Medicines Zhejiang Co., Ltd. |
2024-06-24 | PHASE3 |
| NCT04072042 | RECRUITING | Sarcoma |
Ruijin Hospital |
2019-10-30 | PHASE2 |
| NCT06913777 | RECRUITING | Neoadjuvant Therapy |
Fudan University |
2025-04-08 | PHASE3 |
| NCT06546280 | UNKNOWN | Hepatocellular Carcinoma |
Zhujiang Hospital |
2024-08-26 | PHASE2 |
| NCT06607770 | RECRUITING | Lung Cancer |
Zhou Chengzhi |
2024-09-01 | PHASE1; PHASE2 |
| NCT04639180 | ACTIVE_NOT_RECRUITING | Hepatocellular Carcinoma (HCC) |
Jiangsu HengRui Medicine Co., Ltd. |
2021-04-01 | PHASE3 |
| NCT05320692 | ACTIVE_NOT_RECRUITING | Hepatocellular Carcinoma |
Jiangsu HengRui Medicine Co., Ltd. |
2022-08-09 | PHASE3 |
| NCT05934331 | RECRUITING | Malignant Neoplasms of Digestive Organs |
LaNova Medicines Zhejiang Co., Ltd. |
2023-07-27 | PHASE2 |
| NCT06485466 | RECRUITING | Unresectable Hepatocellular Carcinoma; Transarterial Chemoembolization; Camrelizumab; Apatinib |
Guohui Xu |
2024-08-10 | PHASE3 |
| NCT06281886 | COMPLETED | Esophageal Squamous Cell Carcinoma; Efficacy; Toxicity |
Sun Yat-sen University |
2024-02-15 | PHASE2 |
| NCT06483282 | RECRUITING | Small Cell Lung Cancer Limited Stage |
Jin Ying |
2024-06-21 | PHASE2 |
| NCT07157969 | RECRUITING | HCC - Hepatocellular Carcinoma |
Peking Union Medical College Hospital |
2025-02-19 | PHASE2 |
| NCT06694324 | NOT_YET_RECRUITING | Dedifferentiated Liposarcoma; Soft Tissue Sarcoma (STS) |
Fudan University |
2024-12-01 | PHASE2 |
| NCT06339281 | NOT_YET_RECRUITING | Advanced Breast Cancer |
Li Huiping |
2024-05-01 | PHASE2 |
| NCT06346392 | ACTIVE_NOT_RECRUITING | Gastric Cancer; Gastroesophageal Junction Cancer |
AstraZeneca |
2024-03-04 | PHASE3 |
| NCT06438627 | RECRUITING | Nasopharyngeal Carcinoma |
XIANG YANQUN |
2024-05-30 | PHASE3 |
| NCT06693128 | ACTIVE_NOT_RECRUITING | Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma |
Ruijin Hospital |
2024-11-21 | PHASE2 |
| NCT06349317 | RECRUITING | Hepatocellular Carcinoma |
Yongyi Zeng |
2024-04-22 | PHASE2 |
| NCT06429696 | RECRUITING | Small Cell Lung Cancer Extensive Stage |
Nanfang Hospital, Southern Medical University |
2024-07-14 | PHASE2 |
| NCT06363825 | RECRUITING | Advanced Hepatocellular Carcinoma |
Fujian Medical University |
2024-04-12 | PHASE2 |
| NCT04834674 | COMPLETED | Intrahepatic Cholangiocarcinoma; Transarterial Chemoembolization; Apatinib; PD-1 Antibody |
Sichuan Cancer Hospital and Research Institute |
2024-07-01 | PHASE2 |
| NCT04824352 | SUSPENDED | Effect of Drug; Toxicity, Drug |
Peking University People's Hospital |
2021-04-01 | PHASE2 |
| NCT04342910 | RECRUITING | Gastric Cancer |
Jiangsu HengRui Medicine Co., Ltd. |
2020-09-21 | PHASE3 |
| NCT06792162 | RECRUITING | Gastric Cancer |
Peking University Third Hospital |
2023-04-20 | PHASE2 |
| NCT06280105 | RECRUITING | Hepatocellular Carcinoma |
Meng Chao Hepatobiliary Hospital of Fujian Medical University |
2024-03-31 | PHASE2 |
| NCT07000344 | TERMINATED | Ovarian Cancer |
Peking Union Medical College Hospital |
2025-07-01 | |
| NCT05027386 | COMPLETED | Neuroblastoma |
Sun Yat-sen University |
2021-08-26 | PHASE1; PHASE2 |
| NCT06607107 | RECRUITING | Hepatocellular Carcinoma Non-resectable |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2024-02-17 | PHASE2 |
| NCT05751733 | RECRUITING | Gastrointestinal Stromal Tumors |
Xiangya Hospital of Central South University |
2023-02-01 | |
| NCT06482008 | UNKNOWN | Hepatocellular Carcinoma |
Sun Yat-sen University |
2024-06-19 | PHASE2 |
| NCT04560127 | ACTIVE_NOT_RECRUITING | Radioactive Iodine-refractory Differentiated Thyroid Cancer |
Peking Union Medical College Hospital |
2020-09-23 | PHASE2 |
| NCT05512481 | RECRUITING | Melanoma; Acral Melanoma; Temozolomide; Apatinib; Camrelizumab; Neoadjuvant; Pathological Response |
Peking University Cancer Hospital & Institute |
2022-09-13 | PHASE2 |
| NCT05854849 | RECRUITING | Nasopharyngeal Carcinoma |
Sun Yat-sen University |
2023-05-01 | PHASE3 |
| NCT06188455 | NOT_YET_RECRUITING | Ovarian Cancer |
The First Affiliated Hospital of Xiamen University |
2024-12-01 | PHASE3 |
| NCT05594095 | RECRUITING | Breast Neoplasm; Breast Cancer; Hormone Receptor Positive Tumor; HER2-negative Breast Cancer; Advanced Breast Cancer |
Fudan University |
2022-12-30 | PHASE2 |
| NCT05742750 | COMPLETED | Locally Advanced Biliary Tract Cancer; Metastatic Biliary Tract Cancer |
Sun Yat-sen University |
2023-04-27 | PHASE1; PHASE2 |
| NCT06632522 | NOT_YET_RECRUITING | Liver Cancer |
Beijing Tsinghua Chang Gung Hospital |
2024-10-20 | PHASE2 |
| NCT06418594 | RECRUITING | HER2-negative Breast Cancer Brain Metastases |
Beijing 302 Hospital |
2024-10-10 | PHASE2 |
| NCT05759572 | RECRUITING | Breast Cancer Metastatic |
Fudan University |
2023-02-01 | PHASE2 |
| NCT06102707 | NOT_YET_RECRUITING | Ovarian Cancer Recurrent |
Qilu Hospital of Shandong University |
2023-11-01 | |
| NCT06539091 | NOT_YET_RECRUITING | Epithelial Ovarian Cancer; Efficacy; Safety; Bone Mineral Density; Tolerability |
Anhui Provincial Hospital |
2024-10-01 | PHASE3 |
| NCT06592287 | NOT_YET_RECRUITING | Advanced Gastric Cancer |
Xianglin Yuan |
2024-09-30 | PHASE1; PHASE2 |
| NCT05738434 | RECRUITING | Esophageal Cancer by AJCC V8 Stage |
The First Affiliated Hospital of Zhengzhou University |
2023-03-02 | PHASE2 |
| NCT07026149 | RECRUITING | Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma |
Ruijin Hospital |
2025-06-08 | PHASE2 |
| NCT05556200 | UNKNOWN | Breast Cancer; Triple-Negative Breast Cancer |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2022-12-01 | PHASE2 |
| NCT04501718 | RECRUITING | Recurrent Medulloblastoma |
Beijing Sanbo Brain Hospital |
2020-10-28 | PHASE2 |
| NCT04501705 | RECRUITING | Recurrent Atypical/malignant Meningioma |
Beijing Sanbo Brain Hospital |
2020-08-18 | |
| NCT06464614 | UNKNOWN | Esophageal Cancer |
The First Affiliated Hospital of Henan University of Science and Technology |
2024-07-15 | PHASE2 |
| NCT06480864 | RECRUITING | Small Cell Lung Cancer |
Yunpeng Liu |
2024-08-09 | |
| NCT05412589 | UNKNOWN | Stage III Hepatocellular Cancer (CNLC Staging) |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2022-06-10 | PHASE2 |
| NCT05597527 | UNKNOWN | Ovarian Cancer |
Fujian Cancer Hospital |
2022-11-01 | PHASE2 |
| NCT03164694 | WITHDRAWN | Lung Cancer |
Sun Yat-sen University |
2017-05-20 | PHASE2 |
| NCT05839197 | UNKNOWN | Macrotrabecular Massive Hepatocellular Carcinoma |
Wan-Guang Zhang |
2023-05-05 | PHASE2 |
| NCT05189184 | UNKNOWN | Head and Neck Squamous Cell Carcinoma |
The First Affiliated Hospital of Zhengzhou University |
2022-03-30 | PHASE2 |
| NCT05853172 | UNKNOWN | Gastric Cancer |
Tianjin Medical University Cancer Institute and Hospital |
2023-03-21 | PHASE2 |
| NCT06161272 | UNKNOWN | Ovarian Cancer; High Grade Serous Adenocarcinoma of Ovary; Primary Peritoneal Carcinoma; Fallopian Tube Cancer |
Guangxi Medical University |
2023-12-10 | PHASE2 |
| NCT05699655 | RECRUITING | Immunotherapy Gastrict Cancer |
Fujian Cancer Hospital |
2023-05-10 | PHASE2; PHASE3 |
| NCT03599778 | UNKNOWN | Gastric Carcinoma |
Anhui Provincial Hospital |
2018-09-01 | PHASE1; PHASE2 |
| NCT06140732 | UNKNOWN | Chordoma; Chemotherapy Effect |
Xuanwu Hospital, Beijing |
2023-10-30 | PHASE2 |
| NCT04749394 | UNKNOWN | Locally Advanced Non-Small Cell Lung Cancer |
Chinese Academy of Medical Sciences |
2021-03-17 | PHASE2 |
| NCT06700421 | ACTIVE_NOT_RECRUITING | Unresectable Locally Advanced Non-small Cell Lung Cancer |
Wei Zhou |
2024-08-13 | PHASE2 |
| NCT05451290 | ACTIVE_NOT_RECRUITING | Advanced Biliary Tract Carcinoma |
First Affiliated Hospital of Zhejiang University |
2022-11-01 | PHASE2 |
| NCT06339216 | NOT_YET_RECRUITING | Gastric Cancer |
Chinese PLA General Hospital |
2024-03-20 | PHASE2 |
| NCT04366128 | COMPLETED | Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type |
Rong Tao |
2020-04-25 | |
| NCT06081595 | NOT_YET_RECRUITING | Relapsed Ovarian Cancer |
Jin Li |
2023-10-30 | PHASE2 |
| NCT04714190 | UNKNOWN | Gastric Cancer; HER2 Overexpressing Gastric Carcinoma |
RemeGen Co., Ltd. |
2021-03-24 | PHASE3 |
| NCT06482086 | RECRUITING | Locally Advanced Thyroid Gland Carcinoma |
West China Hospital |
2021-06-01 | PHASE2 |
| NCT05019690 | RECRUITING | Advanced Triple Negative Breast Cancer |
Fujian Cancer Hospital |
2021-10-01 | PHASE1; PHASE2 |
| NCT06125171 | UNKNOWN | Osteosarcoma |
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology |
2024-01 | PHASE2 |
| NCT05760430 | UNKNOWN | Hepatocellular Carcinoma |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2022-12-14 | PHASE2 |
| NCT05313282 | UNKNOWN | C-staged Hepatocellular Carcinoma in BCLC Classification |
Sun Yat-sen University |
2022-06-15 | PHASE3 |
| NCT04581473 | ACTIVE_NOT_RECRUITING | Gastric Adenocarcinoma; Pancreatic Cancer; Gastroesophageal Junction Adenocarcinoma |
CARsgen Therapeutics Co., Ltd. |
2020-10-23 | PHASE1; PHASE2 |
| NCT05062837 | UNKNOWN | Hepatocellular Carcinoma |
Guangxi Medical University |
2021-06-01 | PHASE2; PHASE3 |
| NCT05524974 | NOT_YET_RECRUITING | Locally Advanced Gastric Cancer |
Fujian Medical University |
2022-09-01 | PHASE2 |
| NCT05235100 | COMPLETED | Sarcoma,Soft Tissue; Extremity; Trunk; Intensity-modulated Radiotherapy; Targetd Therapy; Major Wound Complications |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
2021-09-01 | PHASE2 |
| NCT04559607 | UNKNOWN | Hepatocellular Carcinoma |
Zhongda Hospital |
2020-09-11 | |
| NCT05069857 | RECRUITING | Oral Squamous Cell Carcinoma; Neoadjvant Therapy; Anti-PD-1; Anti-VEGFR |
Shanghai Jiao Tong University School of Medicine |
2021-09-01 | PHASE2 |
| NCT04074564 | UNKNOWN | Sarcoma |
HRYZ Biotech Co. |
2019-11-22 | EARLY_PHASE1 |
| NCT04781686 | UNKNOWN | Metastatic Gastric Adenocarcinoma; Metastatic Gastroesophageal Junction Adenocarcinoma |
Zhou Fuxiang |
2021-05-14 | PHASE2 |
| NCT04454905 | UNKNOWN | Intrahepatic Cholangiocarcinoma |
Sun Yat-sen University |
2020-08-01 | PHASE2 |
| NCT05932264 | UNKNOWN | NSCLC; Non-small Cell Lung Cancer |
Sun Yat-sen University |
2023-07 | PHASE2 |
| NCT05156970 | COMPLETED | Recurrent Head and Neck Squamous Cell Carcinoma; Metastatic Head and Neck Squamous Cell Carcinoma |
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University |
2021-06-24 | PHASE2 |
| NCT05216237 | UNKNOWN | Gastric Cancer; Chemotherapy; Immunotherapy |
Jiuda Zhao |
2022-02-15 | PHASE2 |
| NCT04930315 | COMPLETED | Hepatocellular Carcinoma |
Zhejiang University |
2021-09-15 | PHASE2 |
| NCT05380986 | UNKNOWN | Solid Tumor |
Henan Cancer Hospital |
2022-05-20 | |
| NCT05559008 | UNKNOWN | Peripheral T Cell Lymphoma |
Ruijin Hospital |
2022-09-30 | PHASE1; PHASE2 |
| NCT04701060 | COMPLETED | Resectable Hepatocellular Carcinoma |
Tianjin Medical University Cancer Institute and Hospital |
2021-01-26 | PHASE2 |
| NCT05099848 | COMPLETED | Hepatocellular Carcinoma |
Shandong Cancer Hospital and Institute |
2021-03-17 | PHASE2 |
| NCT05142865 | UNKNOWN | Advanced or Metastatic EP-NEC |
Huazhong University of Science and Technology |
2022-01-14 | PHASE2 |
| NCT04974944 | TERMINATED | Stage IVB Cervical Cancer; Recurrent Cervical Cancer; Persistent Cervical Cancer |
Sun Yat-Sen University Cancer Center |
2021-07-30 | PHASE2 |
| NCT05447702 | RECRUITING | Triple Negative Breast Cancer |
West China Hospital |
2022-11-01 | PHASE2 |
| NCT04609176 | UNKNOWN | Gastric Cancer |
Peking University |
2020-11-18 | PHASE2 |
| NCT04191889 | UNKNOWN | C-staged Hepatocellular Carcinoma in BCLC Classification |
Sun Yat-sen University |
2020-04-13 | PHASE2 |
| NCT05400902 | UNKNOWN | Intrahepatic Cholangiocarcinoma |
Binkui Li |
2023-05-31 | PHASE2 |
| NCT04950400 | UNKNOWN | Non-small Cell Lung Cancer |
Beijing Chest Hospital |
2021-07-07 | |
| NCT04318730 | UNKNOWN | Adrenocortical Carcinoma |
West China Hospital |
2020-10-01 | PHASE2 |
| NCT02824458 | UNKNOWN | EGFR Tyrosine Kinase Inhibitors Plus VEGFR Inhibitors |
Sun Yat-sen University |
2016-06 | PHASE3 |
| NCT04517357 | COMPLETED | Relapsed Ovarian Cancer |
Jiangsu HengRui Medicine Co., Ltd. |
2020-10-16 | PHASE2 |
| NCT03742193 | UNKNOWN | Osteosarcoma; Pulmonary Metastases; Apatinib |
Ruijin Hospital |
2019-08-11 | PHASE2 |
| NCT05550025 | UNKNOWN | Hepatocellular Carcinoma |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2021-12-17 | PHASE2 |
| NCT05479487 | UNKNOWN | Relapsed Ovarian Cancer |
Xiaohua Wu MD |
2022-08-01 | PHASE2 |
| NCT04683198 | UNKNOWN | Small-cell Lung Cancer |
Chinese Academy of Medical Sciences |
2021-04-01 | PHASE2 |
| NCT03917966 | UNKNOWN | Locally Advanced Esophageal Squamous Cell Carcinoma |
The First Affiliated Hospital of Zhengzhou University |
2020-04-07 | PHASE2 |
| NCT04588987 | UNKNOWN | Neoadjuvant Therapy; Carilizumab; Apatinib; Recurrent High-Grade Glioma |
Sun Yat-sen University |
2020-10 | PHASE2 |
| NCT05942573 | UNKNOWN | Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ) |
Tianjin Medical University Cancer Institute and Hospital |
2022-12-24 | PHASE2 |
| NCT04625803 | COMPLETED | Colon Cancer; Neoadjuvant Therapy |
Zhejiang University |
2021-01-04 | PHASE2 |
| NCT05549466 | UNKNOWN | Nasopharyngeal Carcinoma |
Sun Yat-sen University |
2022-10-08 | PHASE2 |
| NCT04190745 | UNKNOWN | Gastric Adenocarcinoma |
Zhejiang Cancer Hospital |
2019-11-29 | PHASE2 |
| NCT04715633 | UNKNOWN | Colorectal Cancer; Microsatellite Instability High |
Sun Yat-sen University |
2020-12-01 | PHASE2 |
| NCT04479527 | UNKNOWN | Hepatocellular Carcinoma |
Peking University Cancer Hospital & Institute |
2021-04 | PHASE2 |
| NCT04863430 | WITHDRAWN | Gastric Cancer |
Peking University |
2021-05-11 | PHASE2 |
| NCT05277480 | COMPLETED | Effect of Drug; Drug; Toxicity |
Peking University People's Hospital |
2022-03-01 | PHASE2 |
| NCT04229615 | UNKNOWN | Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Carcinoma |
Jiangsu HengRui Medicine Co., Ltd. |
2020-06-02 | PHASE3 |
| NCT03777124 | TERMINATED | NSCLC Stage IV; KRAS Gene Mutation; PD-1 Antibody; Chemotherapy Effect |
Jiangsu HengRui Medicine Co., Ltd. |
2019-07-11 | PHASE2 |
| NCT04012827 | UNKNOWN | Soft Tissue Sarcoma |
Sun Yat-sen University |
2019-08-20 | PHASE2 |
| NCT03813784 | COMPLETED | Gastric Cancer; GastroEsophageal Cancer |
Jiangsu HengRui Medicine Co., Ltd. |
2019-03-07 | PHASE3 |
| NCT03491631 | UNKNOWN | Tumor, Solid; Cancer, Metastatic; Neoplasm Malignant |
Jiangsu HengRui Medicine Co., Ltd. |
2018-11-20 | PHASE1 |
| NCT04934618 | UNKNOWN | Gastric Cancer |
Nanfang Hospital, Southern Medical University |
2020-05-19 | PHASE2 |
| NCT04459078 | UNKNOWN | Adenocarcinoma of the Lung |
Hunan Cancer Hospital |
2020-08-26 | PHASE2 |
| NCT05342389 | UNKNOWN | Metastatic Gastric Adenocarcinoma; Metastatic Gastroesophageal Junction Adenocarcinoma |
Sixth Affiliated Hospital, Sun Yat-sen University |
2022-05-01 | PHASE2 |
| NCT05290116 | UNKNOWN | Intrahepatic Cholangiocarcinoma |
Yunfei Yuan |
2022-07-21 | PHASE2 |
| NCT05839197 | Recruiting | Macrotrabecular Massive Hepatocellular Carcinoma |
Wan-Guang Zhang|Tongji Hospital |
2023-05-05 | Phase 2 |
| NCT04720131 | COMPLETED | Biliary Tract Cancer; Anti-PD-1 Therapy; Targeted Molecular Therapy; Capecitabine |
Beijing Friendship Hospital |
2021-01-01 | PHASE2 |
| NCT05223088 | COMPLETED | Immunotherapy; Gastrict Cancer |
Fujian Cancer Hospital |
2021-10-31 | PHASE2 |
| NCT04335006 | TERMINATED | Breast Cancer; Triple Negative Breast Cancer |
Jiangsu HengRui Medicine Co., Ltd. |
2020-07-14 | PHASE3 |
| NCT04832204 | UNKNOWN | Solid Tumor |
Beijing Hospital |
2021-03-25 | PHASE2 |
| NCT04723030 | UNKNOWN | Locally Advanced Pancreatic Cancer |
Peking University |
2021-04-01 | PHASE2 |
| NCT05265793 | UNKNOWN | PD-1 Immunotherapy; VEGFR-TKI; Sarcomatoid Carcinoma; Carcinosarcoma |
Fudan University |
2021-11-21 | PHASE2 |
| NCT03982485 | ACTIVE_NOT_RECRUITING | Breast Cancer |
RenJi Hospital |
2018-10-16 | PHASE2 |
| NCT06238752 | COMPLETED | Advanced Gastric Adenocarcinoma |
Renmin Hospital of Wuhan University |
2021-03-01 | PHASE2 |
| NCT05742750 | Not yet recruiting | Locally Advanced Biliary Tract Cancer|Metastatic Biliary Tract Cancer |
Sun Yat-sen University|Jiangsu Hengrui Pharmaceutical Co. Ltd. |
2023-03-01 | Phase 1|Phase 2 |
| NCT05095636 | UNKNOWN | Gastric Cancer; Metastasis |
Fudan University |
2021-03-17 | PHASE2 |
| NCT04258644 | UNKNOWN | Gastric Cancer |
Beijing Friendship Hospital |
2020-03-01 | PHASE2 |
| NCT04569916 | UNKNOWN | Solid Tumor |
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School |
2020-09 | PHASE2 |
| NCT05001412 | UNKNOWN | Extensive Stage Small Cell Lung Cancer |
Zhou Chengzhi |
2021-01-27 | PHASE1 |
| NCT04425135 | UNKNOWN | Lung Neoplasms |
The First Affiliated Hospital of Xiamen University |
2020-07 | PHASE2 |
| NCT04850040 | UNKNOWN | Hepatocellular Carcinoma Resectable |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
2021-05-06 | PHASE2 |
| NCT04722718 | UNKNOWN | Breast Cancer |
Jiuda Zhao |
2021-02-01 | PHASE2 |
| NCT05171309 | UNKNOWN | Hepatocellular Carcinoma |
Nanfang Hospital, Southern Medical University |
2021-01-01 | PHASE2 |
| NCT03365765 | COMPLETED | Apatinib |
Huashan Hospital |
2018-02-12 | PHASE3 |
| NCT05049681 | UNKNOWN | Esophageal Cancer |
Feng Wang |
2021-12-05 | PHASE3 |
| NCT03193814 | WITHDRAWN | Colorectal Cancer; Chemotherapy; Angiogenesis |
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology |
2019-12-01 | PHASE2 |
| NCT04612894 | UNKNOWN | Thyroid Cancer |
Fudan University |
2020-12-01 | PHASE2 |
| NCT04267549 | UNKNOWN | Gastric Cancer Stage IV |
Tianjin Medical University Cancer Institute and Hospital |
2019-05-01 | PHASE2 |
| NCT04303741 | UNKNOWN | Breast Cancer |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2020-03-25 | PHASE2 |
| NCT03741244 | UNKNOWN | Glioma |
The Second Hospital of Hebei Medical University |
2019-05-06 | PHASE2 |
| NCT04547088 | UNKNOWN | Nasopharyngeal Carcinoma |
Sun Yat-sen University |
2020-09 | PHASE2 |
| NCT04878107 | UNKNOWN | Non-Small Cell Lung Cancer |
Wuhan University |
2022-03-15 | PHASE2 |
| NCT04548271 | UNKNOWN | Nasopharyngeal Carcinoma |
Sun Yat-sen University |
2020-09 | PHASE2 |
| NCT03271255 | UNKNOWN | Colorectal Neoplasms; Intestinal Neoplasms; Gastrointestinal Neoplasms; Digestive System Neoplasms |
Shenzhen People's Hospital |
2018-05-23 | PHASE2 |
| NCT04350190 | COMPLETED | Nasopharyngeal Carcinoma |
Wei Jiang |
2021-01-14 | PHASE2 |
| NCT04351308 | UNKNOWN | Osteosarcoma; Survival; Chemotherapy Effect; Toxicity, Drug |
Peking University People's Hospital |
2020-05-01 | PHASE2 |
| NCT04901754 | UNKNOWN | Small Cell Lung Carcinoma |
Henan Cancer Hospital |
2021-07-14 | PHASE2 |
| NCT04523662 | UNKNOWN | Hepatocellular Carcinoma |
Beijing Tsinghua Chang Gung Hospital |
2020-08-30 | PHASE2 |
| NCT04006821 | UNKNOWN | Gastric Cancer; AFP |
China Medical University, China |
2019-07-25 | PHASE2 |
| NCT04195828 | COMPLETED | Advanced Gastric Cancer |
Fujian Medical University |
2020-06-18 | PHASE2 |
| NCT03580395 | UNKNOWN | Breast Cancer |
Hebei Medical University Fourth Hospital |
2017-06-01 | PHASE2; PHASE3 |
| NCT04792515 | UNKNOWN | Locally Advanced Gastric Cancer |
First Affiliated Hospital Xi'an Jiaotong University |
2021-01-01 | PHASE2 |
| NCT04296370 | UNKNOWN | Treatment in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA Mutation |
Jiangsu HengRui Medicine Co., Ltd. |
2020-07-13 | PHASE3 |
| NCT04379739 | ACTIVE_NOT_RECRUITING | Non Small Cell Lung Cancer |
Shanghai Pulmonary Hospital, Shanghai, China |
2020-07-26 | PHASE2 |
| NCT04586088 | UNKNOWN | Nasopharyngeal Carcinoma; Recurrent Nasopharyngeal Carcinoma; Metastatic Nasopharyngeal Carcinoma; Chemotherapy Effect; Immunotherapy; Molecular Targeted Therapy |
Sun Yat-sen University |
2020-05-05 | PHASE2 |
| NCT04415385 | UNKNOWN | Pancreatic Cancer |
Zhejiang Cancer Hospital |
2020-06-01 | PHASE2 |
| NCT03878472 | COMPLETED | Gastric Cancer |
Qilu Hospital of Shandong University |
2019-04-01 | PHASE2 |
| NCT04665362 | UNKNOWN | Advanced/Metastatic Hepatocellular Carcinoma |
Liang Peng |
2021-01-25 | PHASE1 |
| NCT04397770 | UNKNOWN | Melanoma |
Peking University Cancer Hospital & Institute |
2020-05 | PHASE2 |
| NCT04440917 | UNKNOWN | Head and Neck Squamous Cell Carcinoma |
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University |
2020-06-03 | PHASE2 |
| NCT03083041 | COMPLETED | Carcinoma, Non-Small-Cell Lung |
Jiangsu HengRui Medicine Co., Ltd. |
2017-03-13 | PHASE2 |
| NCT04282278 | UNKNOWN | Advanced Solid Tumor |
Hebei Medical University Fourth Hospital |
2020-07-16 | PHASE2 |
| NCT04239443 | UNKNOWN | Advanced Non Small Cell Lung Cancer; Uterine Cancer; Soft Tissue Sarcoma |
Hunan Cancer Hospital |
2019-01-30 | PHASE2 |
| NCT04203485 | UNKNOWN | PD-L1 Positive Non-small Cell Lung Cancer |
Jiangsu HengRui Medicine Co., Ltd. |
2020-06-15 | PHASE3 |
| NCT03889626 | UNKNOWN | Stomach Neoplasms; Gastrointestinal Neoplasms; Stomach Diseases; Digestive System Neoplasms; Capecitabine; Apatinib; Neoplasms; Molecular Mechanisms of Pharmacological Action |
Fudan University |
2019-03-22 | PHASE3 |
| NCT04826406 | UNKNOWN | Hepatocellular Carcinoma; Immune Checkpoint Inhibitors |
Hunan Cancer Hospital |
2021-02-03 | PHASE2 |
| NCT03764293 | COMPLETED | Locally Advanced or Metastatic and Unresectable HCC |
Jiangsu HengRui Medicine Co., Ltd. |
2019-06-10 | PHASE3 |
| NCT05225844 | UNKNOWN | Gastrointestinal Cancer; Immunotherapy; Targeted Therapy |
Harbin Medical University |
2019-01-01 | PHASE2 |
| NCT05025033 | COMPLETED | Gastric Cancer |
Tianjin Medical University Cancer Institute and Hospital |
2019-05-30 | PHASE2 |
| NCT04447274 | UNKNOWN | Sarcoma |
Chinese Academy of Medical Sciences |
2020-07-01 | PHASE2 |
| NCT04101929 | UNKNOWN | Metastatic Pancreatic Cancer |
Fudan University |
2019-10-01 | PHASE2 |
| NCT04035876 | UNKNOWN | Hepatocellular Carcinoma; Liver Transplant |
Zhejiang University |
2019-07-16 | PHASE1; PHASE2 |
| NCT04345783 | UNKNOWN | Gastric Cancer |
Beijing Friendship Hospital |
2018-01-01 | PHASE2 |
| NCT04506242 | UNKNOWN | NSCLC |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
2020-09-15 | PHASE2 |
| NCT04253873 | UNKNOWN | High-grade Gliomas |
WuHui |
2019-12-16 | PHASE2 |
| NCT04985136 | TERMINATED | Advanced Hepatocellular Carcinoma (HCC) |
Jiangsu HengRui Medicine Co., Ltd. |
2021-09-26 | PHASE3 |
| NCT04297202 | UNKNOWN | Hepatocellular Carcinoma |
The First Affiliated Hospital with Nanjing Medical University |
2019-12-01 | PHASE2 |
| NCT05287360 | Completed | Healthy |
Elevar Therapeutics |
2021-12-30 | Phase 1 |
| NCT04201990 | UNKNOWN | Lung Cancer |
ShiYue Li |
2019-12 | PHASE1; PHASE2 |
| NCT04121039 | UNKNOWN | Gastric Adenocarcinoma; Advanced Cancer |
Fujian Cancer Hospital |
2019-12 | PHASE2 |
| NCT03229096 | UNKNOWN | Chemotherapy Effect; Chemotherapeutic Toxicity; Gastric Cancer |
Shanghai Zhongshan Hospital |
2017-02-01 | PHASE2 |
| NCT04204577 | UNKNOWN | BCLC Stage B Hepatocellular Carcinoma; BCLC Stage C Hepatocellular Carcinoma |
Chinese PLA General Hospital |
2019-11-01 | PHASE2 |
| NCT03427242 | UNKNOWN | Biliary Tract Neoplasms |
Fudan University |
2017-11-01 | PHASE2 |
| NCT03801200 | UNKNOWN | NSCLC |
Hubei Cancer Hospital |
2020-09-10 | PHASE2 |
| NCT04428086 | COMPLETED | Solid Tumor, Adult |
Jiangsu HengRui Medicine Co., Ltd. |
2020-07-27 | PHASE1 |
| NCT03075462 | COMPLETED | Ovarian Cancer; Triple Negative Breast Cancer |
Jiangsu HengRui Medicine Co., Ltd. |
2017-03-09 | PHASE1 |
| NCT03254654 | COMPLETED | Advanced Triple-Negative Breast Cancer |
Fudan University |
2017-08-16 | PHASE2 |
| NCT04490421 | UNKNOWN | Lung Neoplasm; Small Cell Lung Cancer; PD-1 Inhibitors |
Fuzhou General Hospital |
2020-08-01 | PHASE3 |
| NCT04659785 | UNKNOWN | Small Cell Lung Cancer Extensive Stage |
Tianjin Medical University Second Hospital |
2020-07-01 | PHASE1; PHASE2 |
| NCT03612219 | UNKNOWN | Nasopharyngeal Carcinoma |
Wei Jiang |
2018-07-01 | PHASE2 |
| NCT04446091 | UNKNOWN | Colorectal Cancer |
Zhejiang Cancer Hospital |
2020-07-01 | PHASE1; PHASE2 |
| NCT04068974 | UNKNOWN | Recurrent Platinum-resistant Ovarian Cancer |
Peking Union Medical College Hospital |
2019-10-28 | PHASE2 |
| NCT03736863 | RECRUITING | Esophageal Cancer |
The First Affiliated Hospital of Zhengzhou University |
2019-12-05 | PHASE2 |
| NCT03609489 | UNKNOWN | Biliary Carcinoma |
First Affiliated Hospital of Guangxi Medical University |
2018-09-10 | PHASE2 |
| NCT04411706 | UNKNOWN | Hepatocellular Carcinoma |
Xin-Hua Xu |
2020-06-21 | PHASE2 |
| NCT03954756 | UNKNOWN | Advanced Gastric Cancer |
Henan Cancer Hospital |
2019-06-01 | PHASE2 |
| NCT03986515 | UNKNOWN | Mucosal Melanoma; Advanced Cancer; Apatinib; SHR-1210 |
Henan Cancer Hospital |
2019-06-04 | PHASE2 |
| NCT04457180 | COMPLETED | Advanced Solid Tumor |
Jiangsu HengRui Medicine Co., Ltd. |
2020-11-16 | PHASE1 |
| NCT04182724 | UNKNOWN | Advanced Gastric Cancer |
Chinese PLA General Hospital |
2019-11-12 | PHASE1; PHASE2 |
| NCT03251417 | TERMINATED | Esophageal Squamous Cell Carcinoma |
Peking University |
2017-09-10 | PHASE2 |
| NCT04322552 | COMPLETED | Advanced Solid Tumor |
Jiangsu HengRui Medicine Co., Ltd. |
2020-03-12 | PHASE1 |
| NCT03092895 | COMPLETED | Advanced Primary Liver Cancer; Advanced Biliary Tract Carcinoma |
Jiangsu HengRui Medicine Co., Ltd. |
2017-04-24 | PHASE2 |
| NCT03709953 | UNKNOWN | Lung Carcinoma |
Guangzhou Institute of Respiratory Disease |
2018-10-19 | PHASE2 |
| NCT04047017 | COMPLETED | Gestational Trophoblastic Disease |
Peking Union Medical College Hospital |
2019-08-08 | PHASE2 |
| NCT03463876 | COMPLETED | Hepatocellular Carcinoma |
Jiangsu HengRui Medicine Co., Ltd. |
2018-03-08 | PHASE2 |
| NCT04690231 | COMPLETED | Effect of Drug; Toxicity, Drug; Secondary Resistance |
Peking University People's Hospital |
2020-12-01 | |
| NCT04202978 | UNKNOWN | Hepatic Metastasis of Colorectal Cancer |
Zhongshan Hospital Xiamen University |
2020-03-01 | PHASE1; PHASE2 |
| NCT03945604 | COMPLETED | Triple Negative Breast Cancer |
Jiangsu HengRui Medicine Co., Ltd. |
2019-06-04 | PHASE1 |
| NCT04682249 | WITHDRAWN | ICC |
Sun Yat-sen University |
2020-12-01 | PHASE2 |
| NCT04348032 | UNKNOWN | Platinum-resistant Recurrent Ovarian Cancer |
Chinese Academy of Medical Sciences |
2018-03-22 | PHASE2 |
| NCT04414852 | UNKNOWN | Subjects With Impaired Renal Function and Healthy Subjects |
Jiangsu HengRui Medicine Co., Ltd. |
2020-06-05 | PHASE1 |
| NCT04000295 | UNKNOWN | Ovarian Cancer |
Jiangsu HengRui Medicine Co., Ltd. |
2019-08-16 | PHASE3 |
| NCT03787251 | WITHDRAWN | Esophageal Neoplasms |
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School |
2019-01-01 | PHASE2 |
| NCT03154983 | UNKNOWN | Metastatic Gastric Cancer |
Zhou Fuxiang |
2017-05-20 | PHASE2 |
| NCT03428022 | UNKNOWN | NSCLC; Apatinib; EGFR-TKI |
Shenzhen People's Hospital |
2017-12-01 | PHASE3 |
| NCT03389256 | UNKNOWN | Lung Diseases; Neoplasms; Respiratory Tract Diseases; Thoracic Neoplasms; Non-Small-Cell Lung |
Sichuan Cancer Hospital and Research Institute |
2018-12-30 | PHASE2 |
| NCT03355612 | UNKNOWN | Gastric Carcinoma |
Tianjin Medical University Cancer Institute and Hospital |
2017-12-20 | PHASE3 |
| NCT04174339 | UNKNOWN | Advanced Gastric Adenocarcinoma |
Fujian Cancer Hospital |
2019-12-10 | |
| NCT04089657 | UNKNOWN | Advanced Metastatic Gastric Cancer |
Fujian Cancer Hospital |
2019-12-01 | PHASE2 |
| NCT03775928 | UNKNOWN | Triple-negative Breast Cancer |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
2018-12-18 | PHASE2 |
| NCT03411967 | UNKNOWN | Lung Cancer |
Zigong No.1 Peoples Hospital |
2018-02-01 | PHASE2 |
| NCT04383977 | UNKNOWN | Ovarian Cancer |
Jiangsu HengRui Medicine Co., Ltd. |
2020-05 | PHASE2 |
| NCT03811054 | UNKNOWN | Non Small Cell Lung Cancer |
Beijing Chest Hospital |
2018-12-01 | PHASE2 |
| NCT04128800 | UNKNOWN | Small Cell Lung Cancer |
Tianjin Medical University Cancer Institute and Hospital |
2019-10 | PHASE2 |
| NCT03475589 | UNKNOWN | Stage IV Cancer |
Sun Yat-sen University |
2018-02-26 | PHASE4 |
| NCT03472365 | COMPLETED | Gastric Cancer; GastroEsophageal Cancer |
Jiangsu HengRui Medicine Co., Ltd. |
2018-04-02 | PHASE2 |
| NCT03758677 | UNKNOWN | Non Small Cell Lung Cancer |
The First Hospital of Jilin University |
2020-08-01 | PHASE2 |
| NCT04393506 | COMPLETED | Oral Cancer; VEGFR2 Inhibitor; Programmed Cell Death 1 Inhibitor; Inductive Therapy |
Shanghai Jiao Tong University School of Medicine |
2020-04-23 | PHASE1 |
| NCT04165174 | UNKNOWN | HCC |
Huazhong University of Science and Technology |
2019-12 | PHASE2 |
| NCT03396211 | COMPLETED | Cancer |
Elevar Therapeutics |
2017-12-22 | PHASE1 |
| NCT03267654 | UNKNOWN | Non-small-cell Lung Cancer |
Qilu Pharmaceutical Co., Ltd. |
2017-10-12 | PHASE2 |
| NCT03743428 | Suspended | Colorectal Neoplasms |
Shenzhen People''s Hospital |
2020-10-22 | Not Applicable |
| NCT04517357 | Unknown status | Relapsed Ovarian Cancer |
Jiangsu HengRui Medicine Co. Ltd. |
2020-10-16 | Phase 2 |
| NCT03397199 | UNKNOWN | Colorectal Cancer |
Henan Cancer Hospital |
2018-01-09 | PHASE2 |
| NCT03267121 | COMPLETED | Head and Neck Squamous Cell Carcinoma |
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University |
2017-10-01 | PHASE2 |
| NCT04067986 | UNKNOWN | Colorectal Cancer Recurrent |
Zhongshan Hospital Xiamen University |
2019-08-20 | PHASE1; PHASE2 |
| NCT02878057 | COMPLETED | Breast Cancer |
Peking University Cancer Hospital & Institute |
2016-05 | PHASE2 |
| NCT03942068 | UNKNOWN | Ovarian Cancer |
Henan Cancer Hospital |
2019-09-01 | PHASE2 |
| NCT03258034 | UNKNOWN | Gastric Cancer |
The First Affiliated Hospital of Zhejiang Chinese Medical University |
2017-08-24 | PHASE2 |
| NCT03702491 | UNKNOWN | Gallbladder Carcinoma |
Eastern Hepatobiliary Surgery Hospital |
2018-08-10 | PHASE2 |
| NCT03377842 | UNKNOWN | Colorectal Cancer; Neoadjuvant Therapy |
Sichuan Provincial People's Hospital |
2018-01-31 | PHASE2 |
| NCT03262545 | UNKNOWN | Angiogenesis Inhibitors，Ovarian Neoplasms |
Sichuan Cancer Hospital and Research Institute |
2017-08-27 | PHASE2 |
| NCT03190239 | WITHDRAWN | Advanced Non-squamous Non-small-cell Lung Cancer |
Xinqiao Hospital of Chongqing |
2017-07-15 | PHASE2 |
| NCT04341090 | COMPLETED | Healthy Subjects |
Jiangsu HengRui Medicine Co., Ltd. |
2020-05-13 | PHASE1 |
| NCT03213587 | UNKNOWN | Nasopharyngeal Carcinoma |
Zhejiang Cancer Hospital |
2017-07-01 | PHASE2 |
| NCT03587129 | TERMINATED | Ovarian Cancer |
First Affiliated Hospital of Harbin Medical University |
2018-07-10 | PHASE2 |
| NCT03913182 | UNKNOWN | Esophageal Squamous Cell Carcinoma; Apatinib; Recurrence; Metastasis |
Shanghai Chest Hospital |
2019-04-02 | PHASE2 |
| NCT02426034 | COMPLETED | Advanced Gastric or Gastroesophageal Junction Adenocarcinoma |
Jiangsu HengRui Medicine Co., Ltd. |
2015-05-15 | PHASE4 |
| NCT03816553 | COMPLETED | Recurrent Cervical Carcinoma; Metastatic Cervical Cancer |
Sun Yat-sen University |
2019-01-19 | PHASE2 |
| NCT03955354 | UNKNOWN | Melanoma |
Peking University Cancer Hospital & Institute |
2019-03-05 | PHASE2 |
| NCT04180007 | UNKNOWN | Thyroid; Metastasis; Apatinib |
Nanjing First Hospital, Nanjing Medical University |
2019-04-10 | PHASE2 |
| NCT03180476 | COMPLETED | Nasopharyngeal Neoplasms |
Sichuan Cancer Hospital and Research Institute |
2017-04-01 | PHASE2 |
| NCT03868852 | UNKNOWN | Childhood Rhabdomyosarcoma |
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine |
2019-01-01 | PHASE1; PHASE2 |
| NCT03701022 | UNKNOWN | NK/T-cell Lymphoma |
Peking University |
2018-10-20 | PHASE2 |
| NCT03603756 | UNKNOWN | Esophageal Squamous Cell Carcinoma |
Chinese Academy of Medical Sciences |
2018-07-31 | PHASE2 |
| NCT03048877 | UNKNOWN | Differentiated Thyroid Cancer |
Peking Union Medical College Hospital |
2016-12 | PHASE3 |
| NCT03349827 | TERMINATED | Peritoneal Metastases From Gastric Cancer |
Wuhan University |
2018-01-05 | |
| NCT03662035 | UNKNOWN | Advanced Pancreatic Cancer |
Changzhou No.2 People's Hospital |
2018-09-15 | PHASE2 |
| NCT03857763 | UNKNOWN | Esophageal Squamous Cell Carcinoma |
Hebei Medical University Fourth Hospital |
2019-03-01 | PHASE2 |
| NCT03654612 | UNKNOWN | Head and Neck Cancer |
China International Medical Foundation |
2018-10-16 | PHASE1; PHASE2 |
| NCT03116555 | UNKNOWN | Metastatic Gastric Adenocarcinoma |
China Medical University, China |
2017-04-05 | PHASE2 |
| NCT03412994 | UNKNOWN | Colorectal Neoplasms |
Liqiang Zhong |
2018-02-28 | PHASE2 |
| NCT02731352 | COMPLETED | Thyroid Cancer |
Peking Union Medical College Hospital |
2016-03-11 | PHASE2 |
| NCT03792503 | WITHDRAWN | Advanced Non-squamous Non-small-cell Lung Cancer |
Xinqiao Hospital of Chongqing |
2019-02 | PHASE4 |
| NCT04152681 | UNKNOWN | Radiation Injuries |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2019-10-17 | PHASE2 |
| NCT03144843 | UNKNOWN | Gastric Cancer |
Sun Yat-sen University |
2017-01-13 | PHASE2 |
| NCT03793725 | UNKNOWN | Hepatocellular Carcinoma |
Yanqiao Zhang |
2019-01-30 | PHASE2 |
| NCT03261791 | UNKNOWN | Carcinoma, Hepatocellular |
Shanghai Zhongshan Hospital |
2017-07-20 | PHASE2 |
| NCT03598348 | UNKNOWN | Gastric Cancer |
Huazhong University of Science and Technology |
2018-01-16 | PHASE3 |
| NCT04260113 | COMPLETED | Efficacy; Toxicity, Drug |
Peking University People's Hospital |
2019-10-01 | |
| NCT03631862 | UNKNOWN | Newly Diagnosed Peripheral T-cell Lymphoma |
Zhengzhou University |
2018-09-01 | PHASE4 |
| NCT04126993 | UNKNOWN | Sarcoma |
Tianjin Medical University Cancer Institute and Hospital |
2019-06-01 | PHASE2 |
| NCT04126811 | UNKNOWN | Soft Tissue Sarcoma |
Tianjin Medical University Cancer Institute and Hospital |
2019-06-01 | PHASE2 |
| NCT03394287 | COMPLETED | Breast Cancer |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2018-01-10 | PHASE2 |
| NCT03650738 | UNKNOWN | Systematic Review of the pCR Rate of Apatinib Combined With Albumin Paclitaxel and Carboplatin Regimen for Neoadjuvant Therapy of Triple-negative Breast Cancer |
The First Affiliated Hospital with Nanjing Medical University |
2018-09-01 | PHASE2 |
| NCT03539172 | UNKNOWN | Soft Tissue and Bone Tumor; Head and Neck Cancer; Sarcoma |
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University |
2018-06-01 | PHASE2 |
| NCT03547375 | UNKNOWN | Ovarian Cancer |
Anhui Provincial Hospital |
2018-06-01 | PHASE2 |
| NCT03645200 | UNKNOWN | Advanced Cancer |
Tianjin Medical University Second Hospital |
2019-07-01 | PHASE1 |
| NCT03546855 | UNKNOWN | Cervical Cancer |
Anhui Provincial Hospital |
2018-06-01 | PHASE2 |
| NCT03104283 | COMPLETED | Gastric Cancer |
Affiliated Hospital of Qinghai University |
2017-06-05 | PHASE2 |
| NCT03912857 | UNKNOWN | Metastatic Colorectal Cancer |
Sun Yat-sen University |
2018-12-01 | PHASE2 |
| NCT02976896 | COMPLETED | Esophageal Squamous Cell Carcinoma |
Yuhong Li |
2016-08 | PHASE2 |
| NCT03788174 | UNKNOWN | Gastric Adenocarcinoma |
Fujian Cancer Hospital |
2019-02-01 | PHASE2 |
| NCT03029013 | UNKNOWN | Cervical Cancer |
Third Military Medical University |
2017-01 | |
| NCT02733107 | UNKNOWN | Non-small Cell Lung Cancer |
Third Military Medical University |
2016-03 | PHASE2 |
| NCT03349866 | UNKNOWN | Gastroesophageal Junction Adenocarcinoma |
Hebei Medical University |
2017-11-30 | PHASE2 |
| NCT03192735 | UNKNOWN | Apatinib Combined; SOX; Neoadjuvant Therapy; Locally Advanced Gastric Cancer |
Chang-Ming Huang, Prof. |
2017-09-01 | PHASE2 |
| NCT03389087 | UNKNOWN | Small Cell Lung Cancer |
Henan Cancer Hospital |
2017-11-29 | PHASE2 |
| NCT03718624 | UNKNOWN | Gastric Cancer With Positive Exfoliative Cancer Cells |
Hebei Medical University |
2018-10-30 | PHASE2 |
| NCT03547804 | COMPLETED | Small-cell Lung Cancer |
The First Hospital of Jilin University |
2018-05-31 | PHASE2 |
| NCT03359018 | COMPLETED | Progression-free Survival; Overall Survival; Clinical Benefit Rate; Toxicity |
Peking University People's Hospital |
2018-01-01 | PHASE2 |
| NCT03334591 | UNKNOWN | Two Different Treatment Methods |
Anhui Provincial Hospital |
2017-10-01 | PHASE2 |
| NCT03707639 | UNKNOWN | Gastric Adenocarcinoma |
Fujian Cancer Hospital |
2018-11 | PHASE2 |
| NCT02943252 | UNKNOWN | Head and Neck Neoplasms |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
2016-10 | PHASE2 |
| NCT03671265 | UNKNOWN | Esophageal Cancer |
Tianjin Medical University Cancer Institute and Hospital |
2018-09-17 | |
| NCT03407976 | TERMINATED | Advanced Malignancies; Urothelial Carcinoma; MSI-H or dMMR Solid Tumors; Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma |
University of Utah |
2018-06-19 | PHASE1 |
| NCT03634059 | UNKNOWN | NSCLC |
Hebei Medical University Fourth Hospital |
2018-08-15 | |
| NCT03651219 | UNKNOWN | Small Cell Lung Cancer |
Beijing Chest Hospital |
2018-09-08 | PHASE3 |
| NCT03219593 | UNKNOWN | Gastric Cancer; Apatinib; Biomarker |
The First Affiliated Hospital of Bengbu Medical University |
2017-09-07 | PHASE2 |
| NCT02942693 | UNKNOWN | Adenoid Cystic Carcinoma |
Shanghai Proton and Heavy Ion Center |
2016-11 | PHASE2 |
| NCT03950141 | UNKNOWN | HER-2 Negatived Gastric Cancer |
Beijing Hospital |
2017-07-01 | PHASE2 |
| NCT03300765 | UNKNOWN | Thyroid Cancer |
Xiayun He, MD |
2017-07-01 | PHASE2 |
| NCT03594682 | UNKNOWN | NSCLC Stage IV; NSCLC Stage IIIB |
Beijing Chest Hospital |
2018-08 | |
| NCT03243643 | UNKNOWN | Advanced Cancer |
Jiangsu Hansoh Pharmaceutical Co., Ltd. |
2017-08-08 | PHASE1 |
| NCT03104335 | WITHDRAWN | Soft Tissue Sarcoma Adult; Advanced Cancer |
Peking University People's Hospital |
2017-04-01 | PHASE2 |
| NCT03190616 | COMPLETED | Colorectal Neoplasms |
The First Affiliated Hospital with Nanjing Medical University |
2017-07-01 | PHASE2 |
| NCT03403452 | UNKNOWN | Colorectal Cancer |
Fudan University |
2018-01-01 | PHASE2 |
| NCT03510416 | UNKNOWN | Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization |
Shanghai Zhongshan Hospital |
2018-05-01 | PHASE2 |
| NCT03285906 | UNKNOWN | Esophagus Cancer, Stage III; Esophageal Gastric Cardia Type Metaplasia; Esophagus Cancer, Stage IV |
Tianjin Medical University Cancer Institute and Hospital |
2017-03-01 | PHASE2; PHASE3 |
| NCT02704767 | UNKNOWN | Lung Cancer |
First Affiliated Hospital of Kunming Medical University |
2016-06 | PHASE2 |
| NCT03725423 | UNKNOWN | Lung Squamous Cell Carcinoma |
Xuzhou Central Hospital |
2018-10 | PHASE4 |
| NCT03050411 | UNKNOWN | Nonsmall Cell Lung Cancer |
Peking University Third Hospital |
2016-05 | PHASE1 |
| NCT03535961 | COMPLETED | Breast Cancer |
Chinese Academy of Medical Sciences |
2017-05-01 | PHASE2 |
| NCT04338438 | COMPLETED | Gastric Cancer |
Beijing Friendship Hospital |
2015-05-01 | PHASE2 |
| NCT03130270 | UNKNOWN | Nasopharyngeal Carcinoma |
Guilin Medical University, China |
2017-01-01 | PHASE2 |
| NCT03127319 | UNKNOWN | Non-squamous Non-small Cell Lung Cancer |
Affiliated Hospital of Hebei University |
2017-07-03 | PHASE2 |
| NCT03256721 | TERMINATED | Nonsmall Cell Lung Cancer |
Fuzhou General Hospital |
2017-08-16 | PHASE2 |
| NCT03114085 | UNKNOWN | Hepatocellular Carcinoma |
First Affiliated Hospital of Guangxi Medical University |
2017-05-20 | PHASE2 |
| NCT03274011 | COMPLETED | Esophageal Neoplasms |
Fudan University |
2017-07-01 | PHASE2 |
| NCT03457467 | UNKNOWN | Breast Cancer |
Yan Li |
2018-03-15 | PHASE2 |
| NCT03144856 | UNKNOWN | Biliary Tract Cancer |
Sun Yat-sen University |
2017-02-22 | PHASE2 |
| NCT03129698 | UNKNOWN | Apatinib in Maintenance Treatment |
Junling Li |
2017-04-11 | PHASE2 |
| NCT03722875 | UNKNOWN | Hepatocellular Carcinoma |
Shanghai Zhongshan Hospital |
2018-12-01 | |
| NCT02980809 | UNKNOWN | Small Cell Lung Cancer |
First Hospitals affiliated to the China PLA General Hospital |
2017-03 | PHASE2 |
| NCT03042611 | COMPLETED | Gastric Cancer; Gastric Adenocarcinoma |
Elevar Therapeutics |
2017-03-14 | PHASE3 |
| NCT03376958 | COMPLETED | Relapsed and Refractory; Diffuse Large B Cell Lymphoma |
Zhengzhou University |
2017-01-01 | PHASE4 |
| NCT02596256 | UNKNOWN | Gastric Cancer |
Chinese PLA General Hospital |
2016-04 | PHASE2 |
| NCT03422445 | UNKNOWN | Advanced Melanoma |
Peking University Cancer Hospital & Institute |
2018-01-08 | PHASE2 |
| NCT03167385 | UNKNOWN | Differentiated Thyroid Carcinoma |
Tianjin Medical University Cancer Institute and Hospital |
2017-03-22 | PHASE2 |
| NCT03255811 | UNKNOWN | Advanced Gastric Cancer |
DongMa |
2017-03-25 | |
| NCT03224221 | UNKNOWN | Esophageal Squamous Cell Carcinoma |
The First Affiliated Hospital of Anhui Medical University |
2017-03-23 | PHASE2 |
| NCT03344614 | UNKNOWN | Colorectal Cancer |
Chinese PLA General Hospital |
2017-07-01 | PHASE2 |
| NCT03416231 | UNKNOWN | NSCLC |
Affiliated Hospital of North Sichuan Medical College |
2016-11-30 | PHASE2 |
| NCT03356600 | UNKNOWN | Brain Metastases |
Shanxi Province Cancer Hospital |
2017-12 | PHASE2 |
| NCT03511703 | UNKNOWN | Hepatocellular Carcinoma |
Guangxi Medical University |
2018-05-01 | PHASE2 |
| NCT03244774 | UNKNOWN | Gastric Adenocarcinoma |
Fujian Cancer Hospital |
2018-01-01 | PHASE1 |
| NCT03520257 | UNKNOWN | Hepatocellular Carcinoma |
Guangxi Medical University |
2018-05-01 | PHASE2 |
| NCT03193424 | UNKNOWN | Advanced Esophageal Squamous Carcinoma |
The First Affiliated Hospital of Zhengzhou University |
2016-10 | PHASE2 |
| NCT03129256 | COMPLETED | Non-small Cell Lung Cancer |
Changzhou Cancer Hospital of Soochow University |
2016-12-01 | PHASE2 |
| NCT02764268 | COMPLETED | Gastric Cancer |
Jiangsu HengRui Medicine Co., Ltd. |
2016-11-02 | |
| NCT03393507 | UNKNOWN | Ovarian Cancer; Chemotherapeutic Toxicity |
The People's Hospital of Leshan |
2017-08-01 | PHASE2 |
| NCT02727309 | UNKNOWN | Hepatocellular Carcinoma |
Peking University Cancer Hospital & Institute |
2015-10 | PHASE1; PHASE2 |
| NCT03542422 | UNKNOWN | Advanced Esophagus Cancer |
Affiliated Hospital of North Sichuan Medical College |
2018-06-30 | PHASE2 |
| NCT02645864 | COMPLETED | Esophageal Squamous Cell Carcinoma |
Peking University |
2016-01 | PHASE1 |
| NCT02989259 | UNKNOWN | Head and Neck Neoplasms |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
2016-12 | PHASE2 |
| NCT03428425 | UNKNOWN | Gastric Cancer |
Hebei Medical University |
2018-02 | PHASE2 |
| NCT03135977 | UNKNOWN | Extensive-stage Small Cell Lung Cancer; Lung Cancer |
Sichuan Cancer Hospital and Research Institute |
2017-03-01 | PHASE2 |
| NCT03652857 | COMPLETED | Advanced Non Small Cell Lung Cancer |
Yongchang Zhang |
2017-01-01 | PHASE2 |
| NCT02874651 | TERMINATED | Nasopharyngeal Neoplasms |
Sun Yat-sen University |
2016-10 | PHASE2 |
| NCT02945852 | COMPLETED | Small Cell Lung Cancer |
Fan Yun, MD |
2016-10 | PHASE2 |
| NCT03121846 | UNKNOWN | Soft Tissue Sarcoma, Adult, Stage II |
Tianjin Medical University Cancer Institute and Hospital |
2017-05-01 | PHASE2 |
| NCT03086785 | UNKNOWN | Breast Cancer Metastatic |
Hebei Medical University Fourth Hospital |
2016-11-24 | PHASE2 |
| NCT03521219 | UNKNOWN | Intrahepatic Cholangiocarcinoma |
The First Affiliated Hospital of Zhengzhou University |
2018-02-07 | PHASE2 |
| NCT03298074 | UNKNOWN | Ovarian Cancer |
Yang Zhijun |
2017-10 | PHASE2 |
| NCT02942329 | UNKNOWN | Gastric Cancer; Hepatocellular Carcinoma |
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences |
2016-10 | PHASE1; PHASE2 |
| NCT02875457 | UNKNOWN | Small Cell Lung Cancer |
Third Military Medical University |
2016-09 | PHASE3 |
| NCT03271073 | UNKNOWN | Gastric Cancer |
Beijing Friendship Hospital |
2016-02-01 | PHASE2 |
| NCT03096184 | UNKNOWN | Head and Neck Squamous Cell Carcinoma |
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University |
2016-12-23 | PHASE2 |
| NCT03030937 | UNKNOWN | Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction |
Fujian Cancer Hospital |
2017-02-01 | PHASE2 |
| NCT03348098 | UNKNOWN | Triple Negative Breast Cancer |
Tianjin Medical University Cancer Institute and Hospital |
2017-09-06 | PHASE2 |
| NCT02848794 | UNKNOWN | High-grade Glioma |
The First People's Hospital of Lianyungang |
2016-07 | PHASE1; PHASE2 |
| NCT02510469 | UNKNOWN | Gastric Cancer |
Hebei Medical University |
2015-07 | PHASE2; PHASE3 |
| NCT03424291 | UNKNOWN | Head and Neck Squamous Cell Carcinoma |
Henan Cancer Hospital |
2017-07-05 | PHASE2 |
| NCT03199677 | UNKNOWN | Refractory Cancer |
Chinese Academy of Medical Sciences |
2017-07-01 | PHASE2 |
| NCT03066557 | UNKNOWN | Hepatocellular Carcinoma |
Jiangsu Cancer Institute & Hospital |
2017-03-15 | |
| NCT03376737 | UNKNOWN | Lung Adenocarcinoma |
Henan Cancer Hospital |
2017-10-12 | PHASE2 |
| NCT02995187 | UNKNOWN | Small Cell Lung Cancer |
Chinese Academy of Medical Sciences |
2016-12 | PHASE2 |
| NCT03245307 | UNKNOWN | Cytochrome P450 Interaction |
Jiangsu HengRui Medicine Co., Ltd. |
2017-08-22 | PHASE1 |
| NCT03210064 | UNKNOWN | Metastatic Colorectal Cancer |
Hui ting Xu，MD |
2017-05-04 | PHASE2 |
| NCT03026881 | UNKNOWN | Recurrent and Metastatic Gastric Cancer |
Jiangsu HengRui Medicine Co., Ltd. |
2017-01 | PHASE1 |
| NCT02697838 | UNKNOWN | Malignant Neoplasm of Stomach Stage II |
Fujian Cancer Hospital |
2016-08-01 | PHASE2 |
| NCT03064243 | UNKNOWN | Soft Tissue Sarcoma |
Shanghai Jiao Tong University Affiliated Sixth People's Hospital |
2017-03-01 | PHASE2 |
| NCT02702323 | UNKNOWN | Hepatocellular Carcinoma; Pulmonary Metastasis |
Zhejiang Cancer Hospital |
2016-03 | PHASE2; PHASE3 |
| NCT03132025 | UNKNOWN | Metastatic Colorectal Cancer |
Yanqiao Zhang |
2017-04-30 | PHASE2 |
| NCT03276156 | UNKNOWN | Gastric Cancer |
Zhejiang Cancer Hospital |
2016-02-23 | PHASE1 |
| NCT03384511 | COMPLETED | Malignancies; Stomach Cancer; Non-small Cell Lung Cancer; Esophageal Cancer; Breast Cancer; Ovary Cancer; Cervical Cancer |
Shandong Cancer Hospital and Institute |
2016-09-30 | PHASE4 |
| NCT02768415 | UNKNOWN | Breast Cancer |
Chinese Academy of Medical Sciences |
2016-06 | PHASE2 |
| NCT02867956 | COMPLETED | Ovarian Cancer |
Sun Yat-sen University |
2016-08-10 | PHASE2 |
| NCT02863367 | UNKNOWN | Metastatic Pancreatic Cancer |
Tianjin Medical University Cancer Institute and Hospital |
2016-08 | PHASE2 |
| NCT02780778 | UNKNOWN | Non-small Cell Lung Cancer |
Tianjin Medical University Cancer Institute and Hospital |
2016-05 | PHASE2; PHASE3 |
| NCT03046979 | UNKNOWN | Hepatocellular Carcinoma |
Tianjin Medical University Cancer Institute and Hospital |
2016-12 | PHASE2 |
| NCT03071042 | UNKNOWN | Metastatic Gastric Adenocarcinoma |
Sir Run Run Shaw Hospital |
2015-10 | PHASE1 |
| NCT02829385 | UNKNOWN | Colorectal Neoplasms |
Shoucheng Ma |
2016-06 | PHASE2 |
| NCT02775370 | UNKNOWN | Adenoid Cystic Carcinoma |
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University |
2016-05 | PHASE2 |
| NCT02509806 | UNKNOWN | Gastric Cancer |
Hebei Medical University |
2015-07 | PHASE2; PHASE3 |
| NCT02726854 | UNKNOWN | Pancreatic Neoplasms |
First Affiliated Hospital Xi'an Jiaotong University |
2016-04 | PHASE2 |
| NCT03320629 | TERMINATED | Refractory or Metastatic Esophageal Squamous Cell Carcinoma |
Hebei Medical University Fourth Hospital |
2017-11-01 | PHASE2 |
| NCT02974933 | UNKNOWN | Nonsmall Cell Lung Cancer |
Wuling Ou |
2016-11 | PHASE2 |
| NCT03163381 | UNKNOWN | Osteosarcoma, Advanced |
Henan Cancer Hospital |
2017-04-11 | PHASE2 |
| NCT02772029 | UNKNOWN | Hepatocellular Carcinoma |
The First Affiliated Hospital of Zhengzhou University |
2016-05 | PHASE1; PHASE2 |
| NCT02332512 | UNKNOWN | Carcinoma, Non-Small-Cell Lung |
Jiangsu HengRui Medicine Co., Ltd. |
2015-01 | PHASE3 |
| NCT02776527 | UNKNOWN | Gastric Cancer |
Tianjin Medical University Cancer Institute and Hospital |
2016-04 | PHASE4 |
| NCT02836171 | COMPLETED | Neoplasms |
Jiangsu HengRui Medicine Co., Ltd. |
2016-07 | PHASE1 |
| NCT02836821 | COMPLETED | Neoplasms |
Jiangsu HengRui Medicine Co., Ltd. |
2016-05 | PHASE1 |
| NCT02998242 | COMPLETED | Quality of Life |
Sichuan Provincial People's Hospital |
2016-05-10 | |
| NCT03660761 | COMPLETED | Efficacy and Safety |
Rongjie Tao |
2016-03-03 | PHASE2 |
| NCT02544737 | UNKNOWN | Esophageal Cancer; Metastatic Esophageal Cancer; Apatinib |
Hangzhou Cancer Hospital |
2015-09 | PHASE2 |
| NCT02774200 | UNKNOWN | Metastatic Renal Cell Carcinoma |
Tianjin Medical University Cancer Institute and Hospital |
2016-05 | PHASE2 |
| NCT02540824 | UNKNOWN | Non-small Cell Lung Cancer |
Tongji University |
2015-01 | PHASE2 |
| NCT02711969 | COMPLETED | Gastric Cancer |
Bukwang Pharmaceutical |
2016-03 | PHASE1 |
| NCT02683655 | UNKNOWN | Esophageal Cancer |
Huai'an First People's Hospital |
2015-08 | PHASE2 |
| NCT02691871 | UNKNOWN | Lung Adenocarcinoma |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
2016-02 | PHASE1 |
| NCT02537171 | UNKNOWN | Gastric Cancer |
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences |
2015-07 | PHASE3 |
| NCT02525237 | UNKNOWN | Gastric Cancer |
Qingdao Municipal Hospital |
2015-08 | PHASE2 |
| NCT01531777 | COMPLETED | Colorectal Cancer |
Jiangsu HengRui Medicine Co., Ltd. |
2011-04 | PHASE2 |
| NCT01176669 | COMPLETED | Metastatic Breast Cancer |
Fudan University |
2010-06 | PHASE2 |
| NCT01192971 | COMPLETED | Advanced Hepatocellular Carcinoma |
Jiangsu HengRui Medicine Co., Ltd. |
2010-06 | PHASE2 |
| NCT01512745 | COMPLETED | Advanced or Metastatic Gastric Cancer |
Jiangsu HengRui Medicine Co., Ltd. |
2011-01 | PHASE3 |
| NCT01287962 | UNKNOWN | Non-small Cell Lung Cancer |
Sun Yat-sen University |
2011-04 | PHASE3 |
| NCT01653561 | COMPLETED | Breast Neoplasms |
Fudan University |
2011-11 | PHASE2 |
| NCT01270386 | COMPLETED | Non-Small-Cell Lung Cancer |
Jiangsu HengRui Medicine Co., Ltd. |
2010-03 | PHASE2 |
| NCT00970138 | COMPLETED | Gastric Carcinoma |
Fudan University |
2009-06 | PHASE2; PHASE3 |
| NCT00633490 | UNKNOWN | Tumor |
Fudan University |
2007-07 | PHASE1 |
(data from https://clinicaltrials.gov, updated on 2026-01-28)
Check the
Apatinib (YN968D1)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
- Apatinib (YN968D1) Mechanism of Action: VEGFR-2 Inhibition in Endothelial Cell Research
- Apatinib (YN968D1): Selectivity & Specificity
- Apatinib (YN968D1) Working Concentration | Cell Culture | Treatment
- Apatinib (YN968D1) Solubility in DMSO
- Apatinib (YN968D1) Stock Solution
- Apatinib (YN968D1) Storage
- Apatinib (YN968D1) Stability
- Apatinib (YN968D1) Combination Database
- Apatinib (YN968D1) Molecular Weight
- Apatinib (YN968D1) SMILES
- Apatinib (YN968D1) CAS Number
- Apatinib (YN968D1) Chemical Structure (2D and 3D)
- Apatinib (YN968D1) IC50 for Cell-based and Cell-free Assays
- Apatinib (YN968D1) Sigma (SML4323)? Try a better option.
- Apatinib (YN968D1) MedChemExpress (HY-13342AS)? Try a better option.
- Apatinib (YN968D1) Cayman (21268)? Try a better option.
- Apatinib (YN968D1) SDS｜MSDS
Note: Technical data last updated: Sep 1, 2026.